A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

NCT02074579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome in Females

Interventions

DRUG: TU-100
DRUG: Placebo

Sponsor

Tsumura USA

Collaborators

[object Object]